Competence Centre on Foresight

Worldwide Many developing countries must now deal with a “dual burden” of disease: they must continue to prevent and control infectious diseases, while also addressing...

90% of all health R&D expenditure is targeted at problems that affect only 10% of the world’s population.| Related Megatrends: Inequalities; TechnologyAbout 20% of health expenditure makes...

Noncommunicable Disease (NCDs) are the leading cause of disability and death in Europe: cardiovascular disease, diabetes, cancer and respiratory disease account for 77% of the burden of disease and 86%...

Priority should increase for prevention and early detection of diseases rather than cure of the symptoms.Use of AI and big data to identify trends in health by regions, for encouraging prevention of potential...

Policies to address practices, prices, and research priorities of the pharmaceutical industry are needed. Public funding for basic research should increase, to ensure expansion of responsible and socially-needed...

The pharmaceutical industry is increasingly driven by the need to move from treatment to prevention, diagnostics and cure, therefore speeding up innovation and implementation of new technological developments. By 2030, the pharmaceutical industry...

Assistive medical technologies; genetic engineering; highly specific drugs; molecular diagnostics and therapy tools with individualised approach at the cellular level are only some of the trends...

Ischaemic heart disease and stroke have been the world’s top causes of death for the past 15 years (accounting for a combined 15 million deaths in 2015) and are...

Over 70% – 41 million of total 56 million global deaths are due to noncommunicable diseases (NCDs) with significant differences by countries and regions. |...

There is increasing attention to preventive medicine, genetic manipulation to eliminate risks (CRISPR), lifestyle changes, etc. The “new patient” concept implies that patients are not...